Evan W. Newell

Characterization of a novel metabolic strategy used by drug-resistant tumor cells

Acquired or inherent drug resistance is the major problem in achieving successful cancer treatment. However, the mechanism(s) of pleiotropic drug resistance remains obscure. We have identified and characterized a cellular metabolic strategy that differentiates drug‐resistant cells from drug‐sensitive cells. This strategy may serve to protect drug‐resistant cells from damage caused by chemotherapeutic agents and radiation. We show that drug‐resistant cells have low mitochondrial membrane potential, use nonglucose carbon sources (fatty acids) for mitochondrial oxygen consumption when glucose becomes limited, and are protected from exogenous stress such as radiation. In addition, drug‐resistant cells express high levels of mitochondrial uncoupling protein 2 (UCP2). The discovery of this metabolic strategy potentially facilitates the design of novel therapeutic approaches to drug resistance.—Harper, M.‐E., Antoniou, A., Villalobos‐Menuey, E., Russo, A., Trauger, R., Vendemelio, George, A. M., Bartholomew, R., Carlo, D., Shaikh, A., Kupperman, J., Newell, E. W., Bespalov, I. A., Wallace, S. S., Liu, Y., Rogers, J. R., Gibbs, G. L., Leahy, J. L., Camley, R. E., Melamede, R., Newell, M. K. Characterization of a novel metabolic strategy used by drug‐resistant tumor cells. FASEB J. 16, 1550–1557 (2002)

Regulation of a TRPM7-like Current in Rat Brain Microglia

Non-excitable cells use Ca2+ influx for essential functions but usually lack voltage-gated Ca2+ channels. The main routes of Ca2+ entry appear to be store-operated channels or Ca2+-permeable non-selective cation channels, of which the magnesium-inhibited cation (or magnesium-nucleotide-regulated metal cation) current has received considerable recent attention. This current appears to be produced by one of the recently cloned transient receptor potential (TRP) channels, TRPM7. In this study of rat microglia, we identified TRPM7 transcripts and a prevalent current with the hallmark biophysical and pharmacological features of TRPM7. This is the first identification of a TRPM7-like current in the brain. There is little known about how members of the TRPM sub-family normally become activated. Using whole-cell patch clamp recordings from rat microglia, we found that the TRPM7-like current activates spontaneously after break-in and that the current and its activation are inhibited by elevated intracellular Mg2+ but not affected by cell swelling or a wide range of intracellular Ca2+ concentrations. The TRPM7-like current in microglia appears to depend on tyrosine phosphorylation. It was inhibited by several tyrosine kinase inhibitors, including a peptide (Src 40–58) that was shown previously to inhibit Src actions, but not by inactive drugs or peptide analogues. The current did not depend on the cell activation state; i.e. it was the same in microglia recently removed from the brain or when cultured under a wide range of conditions that favor the resting or activated state. Because TRPM7 channels are permeable to Ca2+, this current may be important for microglia functions that depend on elevations in intracellular Ca2+.

The Ca2+ release-activated Ca2+ current (ICRAC) mediates store-operated Ca2+ entry in rat microglia

Ca2+ signaling plays a central role in microglial activation, and several studies have demonstrated a store-operated Ca2+ entry (SOCE) pathway to supply this ion. Due to the rapid pace of discovery of novel Ca2+ permeable channels, and limited electrophysiological analyses of Ca2+ currents in microglia, characterization of the SOCE channels remains incomplete. At present, the prime candidates are ‘transient receptor potential’ (TRP) channels and the recently cloned Orai1, which produces a Ca2+-release-activated Ca2+ (CRAC) current. We used cultured rat microglia and real-time RT-PCR to compare expression levels of Orai1, Orai2, Orai3, TRPM2, TRPM7, TRPC1, TRPC2, TRPC3, TRPC4, TRPC5, TRPC6 and TRPC7 channel genes. Next, we used Fura-2 imaging to identify a store-operated Ca2+ entry (SOCE) pathway that was reduced by depolarization and blocked by Gd3+, SKF-96365, diethylstilbestrol (DES), and a high concentration of 2-aminoethoxydiphenyl borate (50 μM 2-APB). The Fura-2 signal was increased by hyperpolarization, and by a low concentration of 2-APB (5 μM), and exhibited Ca2+-dependent potentiation. These properties are entirely consistent with Orai1/CRAC, rather than any known TRP channel and this conclusion was supported by patch-clamp electrophysiological analysis. We identified a store-operated Ca2+ current with the same properties, including high selectivity for Ca2+ over monovalent cations, pronounced inward rectification and a very positive reversal potential, Ca2+-dependent current potentiation, and block by SKF-96365, DES and 50 μM 2-APB. Determining the contribution of Orai1/CRAC in different cell types is crucial to future mechanistic and therapeutic studies; this comprehensive multi-strategy analysis demonstrates that Orai1/CRAC channels are responsible for SOCE in primary microglia.

Integration of K + and Cl - currents regulate steady-state and dynamic membrane potentials in cultured rat microglia

The role of ion channels and membrane potential (Vm) in non‐excitable cells has recently come under increased scrutiny. Microglia, the brains resident immune cells, express voltage‐gated Kv1.3 channels, a Kir2.1‐like inward rectifier, a swelling‐activated Cl– current and several other channels. We previously showed that Kv1.3 and Cl– currents are needed for microglial cell proliferation and that Kv1.3 is important for the respiratory burst. Although their mechanisms of action are unknown, one general role for these channels is to maintain a negative Vm. An impediment to measuring Vm in non‐excitable cells is that many have a very high electrical resistance, which makes them extremely susceptible to leak‐induced depolarization. Using non‐invasive Vm‐sensitive dyes, we show for the first time that the membrane resistance of microglial cells is several gigaohms; much higher than the seal resistance during patch‐clamp recordings. Surprisingly, we observed that small current injections can evoke large Vm oscillations in some microglial cells, and that injection of sinusoidal currents of varying frequency exposes a strong intrinsic electrical resonance in the 5‐ to 20‐Hz frequency range in all microglial cells tested. Using a dynamic current clamp that we developed to actively compensate for the damage done by the patch‐clamp electrode, we found that the Vm oscillations and resonance were more prevalent and larger. Both types of electrical behaviour required Kv1.3 channels, as they were eliminated by the Kv1.3 blocker, agitoxin‐2. To further determine how the ion currents integrate in these cells, voltage‐clamp recordings from microglial cells displaying these behaviours were used to analyse the biophysical properties of the Kv1.3, Kir and Cl– currents. A mathematical model that incorporated only these three currents reproduced the observed Vm oscillations and electrical resonance. Thus, the electrical behaviour of this ‘non‐excitable’ cell type is much more complex than previously suspected, and might reflect a more common oversight in high resistance cells.

Small‐conductance Cl– channels contribute to volume regulation and phagocytosis in microglia

The shape and volume of microglia (brain immune cells) change when they activate during brain inflammation and become migratory and phagocytic. Swollen rat microglia express a large Cl– current (IClswell), whose biophysical properties and functional roles are poorly understood and whose molecular identity is unknown. We constructed a fingerprint of useful biophysical properties for comparison with IClswell in other cell types and with cloned Cl– channels. The microglial IClswell was rapidly activated by cell swelling but not by voltage, and showed no time‐dependence during voltage‐clamp steps. Like IClswell in many cell types, the halide selectivity sequence was I– > Br– > Cl– > F–. However, it differed in lacking inactivation, even at +100 mV with high extracellular Mg2+, and in having a much lower single‐channel conductance: 1–3 pS. Based on these fundamental differences, the microglia channel is apparently a different gene product than the more common intermediate‐conductance IClswell. Microglia express several candidate genes, with relative mRNA expression levels of: CLIC1 > ClC3 > ICln ≥ ClC2 > Best2 > Best1 ≥ Best3 > Best4. Using a pharmacological toolbox, we show that all drugs that reduced the microglia current (NPPB, IAA‐94, flufenamic acid and DIOA) increased the resting cell volume in isotonic solution and inhibited the regulatory volume decrease that followed cell swelling in hypotonic solution. Both channel blockers tested (NPPB and flufenamic acid) dose‐dependently inhibited microglia phagocytosis of E. coli bacteria. Because IClswell is involved in microglia functions that involve shape and volume changes, it is potentially important for controlling their ability to migrate to damage sites and phagocytose dead cells and debris.

Reversed Na+/Ca2+ Exchange Contributes to Ca2+ Influx and Respiratory Burst in Microglia

Phagocytosis and the ensuing NADPH-mediated respiratory burst are important aspects of microglial activation that require calcium ion (Ca2+) influx. However, the specific Ca2+ entry pathway(s) that regulates this mechanism remains unclear, with the best candidates being surface membrane Ca2+-permeable ion channels or Na+/Ca2+ exchangers. In order to address this issue, we used quantitative real-time RT-PCR to assess mRNA expression of the Na+/Ca2+ exchangers, Slc8a1-3/NCX1-3, before and after phagocytosis by rat microglia. All three Na+/Ca2+ exchangers were expressed, with mRNA levels of NCX1 > NCX3 > NCX2, and were unaltered during the one hour phagocytosis period. We then carried out a biophysical characterization of Na+/Ca2+ exchanger activity in these cells. To investigate conditions under which Na+/Ca2+ exchange was functional, we used a combination of perforated patch-clamp analysis, fluorescence imaging of a Ca2+ indicator (Fura-2) and a Na+ indicator (SBFI), and manipulations of membrane potential and intracellular and extracellular ions. Then, we used a pharmacological toolbox to compare the contribution of Na+/Ca2+ exchange with candidate Ca2+-permeable channels, to the NADPH-mediated respiratory burst that was triggered by phagocytosis. We find that inhibiting the reversed mode of the Na+/Ca2+ exchanger with KB-R7943, dose dependently reduced the phagocytosis-stimulated respiratory burst; whereas, blockers of store-operated Ca2+ channels or L-type voltage-gated Ca2+ channels had no effect. These results provide evidence that Na+/Ca2+ exchangers are potential therapeutic targets for reducing the bystander damage that often results from microglia activation in the damaged CNS.

Regulation of hERG and hEAG channels by Src and by SHP-1 tyrosine phosphatase via an ITIM region in the cyclic nucleotide binding domain.

Members of the EAG K+ channel superfamily (EAG/Kv10.x, ERG/Kv11.x, ELK/Kv12.x subfamilies) are expressed in many cells and tissues. In particular, two prototypes, EAG1/Kv10.1/KCNH1 and ERG1/Kv11.1/KCNH2 contribute to both normal and pathological functions. Proliferation of numerous cancer cells depends on hEAG1, and in some cases, hERG. hERG is best known for contributing to the cardiac action potential, and for numerous channel mutations that underlie ‘long-QT syndrome’. Many cells, particularly cancer cells, express Src-family tyrosine kinases and SHP tyrosine phosphatases; and an imbalance in tyrosine phosphorylation can lead to malignancies, autoimmune diseases, and inflammatory disorders. Ion channel contributions to cell functions are governed, to a large degree, by post-translational modulation, especially phosphorylation. However, almost nothing is known about roles of specific tyrosine kinases and phosphatases in regulating K+ channels in the EAG superfamily. First, we show that tyrosine kinase inhibitor, PP1, and the selective Src inhibitory peptide, Src40-58, reduce the hERG current amplitude, without altering its voltage dependence or kinetics. PP1 similarly reduces the hEAG1 current. Surprisingly, an ‘immuno-receptor tyrosine inhibitory motif’ (ITIM) is present within the cyclic nucleotide binding domain of all EAG-superfamily members, and is conserved in the human, rat and mouse sequences. When tyrosine phosphorylated, this ITIM directly bound to and activated SHP-1 tyrosine phosphatase (PTP-1C/PTPN6/HCP); the first report that a portion of an ion channel is a binding site and activator of a tyrosine phosphatase. Both hERG and hEAG1 currents were decreased by applying active recombinant SHP-1, and increased by the inhibitory substrate-trapping SHP-1 mutant. Thus, hERG and hEAG1 currents are regulated by activated SHP-1, in a manner opposite to their regulation by Src. Given the widespread distribution of these channels, Src and SHP-1, this work has broad implications in cell signaling that controls survival, proliferation, differentiation, and other ERG1 and EAG1 functions in many cell types.